Respiratory viruses other than influenza virus: impact and therapeutic advances
- PMID: 18400797
- PMCID: PMC2292575
- DOI: 10.1128/CMR.00045-07
Respiratory viruses other than influenza virus: impact and therapeutic advances
Abstract
Though several antivirals have been developed and marketed to treat influenza virus infections, the development of antiviral agents with clinical activity against other respiratory viruses has been more problematic. Here we review the epidemiology of respiratory viral infections in immunocompetent and immunocompromised hosts, examine the evidence surrounding the currently available antivirals for respiratory viral infections other than influenza, highlight those that are in the pipeline, and discuss the hurdles for development of such agents.
References
-
- Alymova, I. V., G. Taylor, T. Takimoto, T. H. Lin, P. Chand, Y. S. Babu, C. Li, X. Xiong, and A. Portner. 2004. Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo. Antimicrob. Agents Chemother. 48:1495-1502. - PMC - PubMed
-
- American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. 2006. Diagnosis and management of bronchiolitis. Pediatrics 118:1774-1793. - PubMed
-
- Angeles Marcos, M., M. Camps, T. Pumarola, J. Antonio Martinez, E. Martinez, J. Mensa, E. Garcia, G. Penarroja, P. Dambrava, I. Casas, M. T. Jimenez de Anta, and A. Torres. 2006. The role of viruses in the aetiology of community-acquired pneumonia in adults. Antiviral Ther. 11:351-359. - PubMed
-
- Aslan, T., A. B. Fassas, R. Desikan, D. Siegel, N. Munshi, J. Mehta, S. Singhal, B. Barlogie, and E. Anaissie. 1999. Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy. Bone Marrow Transplant. 24:505-509. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical